ROCK inhibitor BDP5290, Purity ≥98%

Synonym: 1817698-21-7; BDP 5290; BDP-5290; ROCK inhibitor

Product Size

2 mg; 5 mg; 10 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

BDP5290 blocks the ATP-binding site of ROCK, thereby inhibiting its kinase activity. It targets MRCKα, MRCKβ, ROCK1, and ROCK2.

Molecular Weight

371.82

Molecular Formula

C₁₇H₁₈ClN₇O

Targets

MRCKα: 10 nM; MRCKβ: 100 nM; ROCK1: 5 nM; ROCK2: 50 nM

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Applications

BDP5290 can be used to explore ROCK inhibition for therapeutic applications in neurological disorders.